We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
TransTech Pharma Selects Genedata to Enhance High Throughput Screening Analysis
News

TransTech Pharma Selects Genedata to Enhance High Throughput Screening Analysis

TransTech Pharma Selects Genedata to Enhance High Throughput Screening Analysis
News

TransTech Pharma Selects Genedata to Enhance High Throughput Screening Analysis

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "TransTech Pharma Selects Genedata to Enhance High Throughput Screening Analysis"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Genedata has announced that TransTech Pharma has signed a multi-year license for high throughput screening analysis software Genedata Screener®.

Scientists at TransTech Pharma will use Screener to enhance their efforts to develop small molecules as therapeutics for treating human diseases. 

"We sought a solution that could be deployed seamlessly with our drug discovery workflow," explained Dr. Robert Rothlein, Senior VP Biology at TransTech Pharma, Inc.

Screener has been integrated with TransTech Pharma’s IT and screening infrastructure. It will automate data quality evaluation and standardize the analysis of compound bioactivity.

Dr. Robert added, "Genedata’s solution saves time and cost in the lead discovery workflow."

"Screener’s modular design and open architecture were important factors in the success of our deployment at TransTech Pharma," says Dr. Michael Lindemann, Business Head Genedata Screener.

TransTech Pharma have developed a highly parallel and integrated Translational Technology® that links together drug design, synthesis and screening.

"We are able to support and enhance this workflow without resource-intensive customization of the Screener platform."

Advertisement